Spyre Therapeutics
SYRE
#5838
Rank
NZ$1.37 B
Marketcap
$22.85
Share price
-8.58%
Change (1 day)
-61.07%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -NZ$0.35 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.38 Billion62.23%
2023 -NZ$0.23 Billion51.64%
2022 -NZ$0.16 Billion29.14%
2021 -NZ$0.12 Billion-19.43%
2020 -NZ$0.15 Billion1.43%
2019 -NZ$0.15 Billion76.7%
2018 -NZ$81.23 Million64.27%
2017 -NZ$49.45 Million26.34%
2016 -NZ$39.14 Million93.6%
2015 -NZ$20.22 Million27.08%
2014 -NZ$15.91 Million